Table 5.

Time to remission of different groups evaluated by combination of serum anti-PLA2R and glomerular PLA2R antigen.

	Remission time (months)
	Serum− & tissue-	Serum− & tissue+	Serum < 150 & tissue−	Serum < 150 & tissue+	Serum ≥ 150 & tissue−	Serum ≥ 150 & tissue+
PR	3.0 (1.75–5.5)	4.0 (2.0–5.5)	4.0 (2.25–6.0)	3.0 (3.0–6.5)	6.0 (4.0–8.0)	8.0 (3.0–9.0)
CR	6.0 (3.0–8.5)	8.0 (6.0–11.0)*	4.0 (2.0–6.0)*a#	5.5 (3.25–9.0)	9.0 (7.0–11.0)a	10.5 (3.25–11.75)#

Time to complete remission: *serum < 150 & tissue⁻ versus serum⁻ & tissue⁺, p = 0.014.

^aSerum < 150 & tissue⁻ versus serum ≥ 150 & tissue⁻, p = 0.032.

^#Serum < 150 & tissue⁻ versus serum ≥ 150 & tissue⁺, p = 0.036.

CR: complete remission; PR: partial remission.